Background/introduction MSM are at increased STI risk. Easily accessible and thorough STI screening should be available to all MSM. BASHH recommendations for MSM STI screening include guidance about which tests to offer and to whom, and suggested frequency of testing.

Aim(s)/objectives To ascertain if our service is following the 2014 BASHH recommendations for MSM STI screening.

Methods 97 MSM attending December 2014 to July 2015 coded T2 and T4, (Chlamydia and Gonorrhoea screening performed and Chlamydia, Gonorrhoea, HIV and Syphilis screening performed respectively), and MSM requesting post exposure prophylaxis (PEP) were included.

Results 3% met Hepatitis C screening recommendations but were not offered testing. Hepatitis C risk factors were not always documented so it is likely more patients should have been offered Hepatitis C screening. Some tests were not indicated for every patient, for example Chlamydia and Gonorrhoea screening is not routinely offered until the 2 week visit for patients attending for PEP due to the 2 week window period for these infections.

Discussion/conclusion BASHH recommend 97% of MSM attending a sexual health service with a new episode of care should be offered STI screening with 80% uptake. Targets for offering HIV and Syphilis screening were achieved but targets for offering Chlamydia, Gonorrhoea and Hepatitis B screening were not met and need to be improved upon. The results also highlighted screening for Hepatitis C risk factors (such as chemsex) needs to be routinely undertaken. The target for STI screening uptake in all areas was achieved. Repeat STI testing needs to be routinely offered to MSM.